Ignite Creation Date:
2024-05-05 @ 11:56 AM
Last Modification Date:
2024-10-26 @ 9:17 AM
Study NCT ID:
NCT00185237
Status:
COMPLETED
Last Update Posted:
2014-12-23
First Post:
2005-09-09
Brief Title:
Treatment of Hot Flushes in Asian Women With Ultra-low Dose Estradiol Patch
Sponsor:
Bayer
Organization:
Bayer
Study Overview
Official Title:
A Multicenter Double-blind Randomized Placebo Controlled Study on the Effect of Ultra-low Dose Transdermal Estradiol Menostar on the Incidence and Severity of Hot Flushes Other Menopausal Symptoms and on Well-being in Postmenopausal Asian Women Over 12 Weeks
Status:
COMPLETED
Status Verified Date:
2014-12
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
150 postmenopausal Asian women with vasomotor symptoms after fulfilling the inclusion and exclusion criteria will be enrolled in the study The women will be randomly assigned to one of two treatment groups Menostar or placebo after which they will be asked to use a patch once a week for 12 weeks
Detailed Description:
The study has previously been posted by Schering AG Germany Schering AG Germany has been renamed to Bayer Schering Pharma AG GermanyBayer Schering Pharma AG Germany is the sponsor of the trial
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None
Secondary IDs
| Secondary ID | Type | Domain | Link |
|---|---|---|---|
| 309120 | None | None | None |